Allarity Therapeutics, Inc. business relationships

Companies named in Allarity Therapeutics, Inc.’s 10-K filed 2026-03-30, and public companies whose annual reports name Allarity Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.7 / 10
AI naming: 4 / 100
Agent readiness: 35 / 100
AI adoption: 0 / 100

Named in Allarity Therapeutics, Inc.’s annual report 9

NOVARTIS AG (NVS)Licensor7.7
“License Agreement with Novartis for Dovitinib” SEC filing
ASTRAZENECA PLC (AZN)Partner7.7
“...ed and/or are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") a...” SEC filing
BRISTOL MYERS SQUIBB CO (BMY)Partner7.7
“...are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") and Roche.” SEC filing
Merck & Co., Inc. (MRK)Partner7.7
“...are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") and Roche.” SEC filing
PFIZER INC (PFE)Partner7.7
“...are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") and Roche.” SEC filing
REGENERON PHARMACEUTICALS, INC. (REGN)Partner7.7
“...are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") and Roche.” SEC filing
Roche GroupPartner7.7
“...are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") and Roche.” SEC filing
Sanofi (SNY)Partner6.7
“...are developing such treatments for cancer including large pharmaceutical and biotechnology companies, such as AstraZeneca plc, Bristol-Myers Squibb Company ("BMS"), Merck, Pfizer in partnership with Merck KGaA, Regeneron Pharmaceuticals, Inc. in partnership with Sanofi Genzyme ("Sanofi") and Roche.” SEC filing
Eisai Inc.Licensor3.5
“License Agreement with Eisai Inc. for Stenoparib” SEC filing

Companies whose annual reports name Allarity Therapeutics, Inc. 1

Lantern Pharma Inc. (LTRN)names it as licensee6.1
“LP-100 was previously out-licensed by us to Allarity Therapeutics A/S.” SEC filing

Links are read automatically from public company filings, so every link carries the sentence it came from.

Not investment advice. Scores, rankings and connections are automated estimates from public sources, provided as is. Connections are read automatically from public company filings and may be incomplete or wrong. To correct or remove a company page or a connection, email [email protected]. Company names and logos belong to their owners. Showing them does not mean the company endorses Engagemii or that Engagemii endorses it. Terms